CLINICAL TRIAL SUMMARY

MDACC Study No:2007-0193 (clinicaltrials.gov NCT No: NCT00438906)
Title:SCREENING FOR EARLY PANCREATIC NEOPLASIA IN HIGH RISK INDIVIDUALS: THE LUSTGARTEN FOUNDATION-NCI SPORE CANCER OF THE PANCREAS SCREENING STUDY (CAPS 3)
Principal Investigator:Jeffrey H. Lee
Treatment Agent:None
Study Status:Closed
Study Description:The goal of this clinical research study is to see if pancreatic cancer can be
found before any signs or symptoms of the disease are shown.

Hide details for General InformationGeneral Information

Disease Group:Pancreas
Phase of Study:N/A
Treatment Agents:None
Treatment Location:Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions
Estimated Length of Stay in Houston:Participation in this study will increase the length or frequency of
hospitalization for the subjects.
Supported By:THE LUSTGARTEN FOUNDATION-NCI SPORE CANCER OF THE PANCREAS SCREENING STUDY
Return Visit:Study participants will not return to MDACC for study visits. All of the
patient follow-up will be standard of care. One study follow-up phone call
will be made to the patients.
Home Care:No treatment will be given or available at home


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Jeffrey H. Lee
Dept:Gastroenterology/Hepatology and Nutrition
For Clinical Trial Enrollment:713-794-5073
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults